. HSA21 genes are over-expressed as a consequence of triplication of chromosome 21 (i.e., trisomy 21), resulting in genedosage imbalance (Reeves, Baxter, & Richtsmeier, 2001 ). Broad developmental, anatomical, and health consequences have been quantified in humans and several types of DS mouse models across multiple investigations (Hill, Reeves, & Richtsmeier, 2007 ; McElyea how dosage imbalance of HSA21 genes affects morphogenesis are not well understood.
Individuals with DS invariably exhibit a characteristic facial morphology and impaired cognition, although the severity of these manifestations varies from person to person (Megarbane et al., 2009; Roper & Reeves, 2006) . Facial features associated with DS can include epicanthic folds, oblique palpebral fissures, a depressed nasal bridge, an upturned nose, reduced mandibular and maxillary size, midfacial retrusion (hypoplasia), impaired craniofacial growth, a relatively short
face, an open-mouthed facial posture that may include a protruding tongue, and numerous other anatomical changes (Pueschel, 2000) .
While the face is affected in all people with DS, the degree of anatomical change in osseous and soft-tissue craniofacial characteristics induced by trisomy 21 during morphogenesis and subsequent growth varies on a person by person basis (Alio, Lorenzo, & Iglesias, 2008; Yahya-Graison et al., 2007) .
Reports of increased phenotypic variation in individuals with DS
are often based on limited qualitative assessments (Bersu, 1980; Dunlap, Aziz, & Rosenbaum, 1986) . Although qualitative labels are useful for identifying and grouping facial features of individuals with DS, such labels may be poorly defined and subject to experience level of the person assessing features. These factors may influence data collection, analysis, and could potentially obscure true patterns of anatomical change associated with trisomy 21 and its impact on morphogenesis and growth. Many studies that have attempted to quantify variance associated with samples of individuals with DS have used only a few relatively simple measures of the palate, teeth, and dermatoglyphics (e.g., Barden, 1980; Shapiro, 1975; Shapiro, Gorlin, Redman, & Bruhl, 1967) . Moreover, many early investigations of craniofacial morphology and variance in samples of individuals with DS were based on two-dimensional analyses from lateral or frontal cephalograms that cannot adequately capture variation and surface topography in three dimensions (e.g., Frostad & Cleall, 1971; Kisling, 1966; O'Riordan, 1979) . Interestingly, in one three-dimensional study of facial morphology Italian subjects with DS were found to have smaller facial size and mean z-scores falling outside the normal interval when compared to normal sex-, ethnic-, and age-matched controls (Sforza, Dellavia, Dolci, Donetti, & Ferrario, 2005 ). An additional investigation found differences in variance between Italian and Northern Sudanese subjects with DS, suggesting that patterns of variation may be influences by ethnic background (Sforza et al., 2015) .
It has been argued that trisomy 21 alters facial morphology sufficiently to obscure family resemblance completely (Opitz & Gilbert-Barness, 1990) , although previous quantitative attempts to evaluate facial similarity between individuals with DS and their siblings were inconclusive (Shaner, Peterson, Beattie, & Bamforth, 2001 ). In samples of unaffected individuals, the resemblance between relatives is easily recognized by most observers, and different studies have shown that facial dimensions of both osseous and soft tissue are heritable (Baydas, Erdem, Yavuz, & Ceylan, 2007; Sherwood et al., 2008) . Therefore, we might expect family resemblance in facial appearance between individuals with DS and their euploid siblings since they share, on average, 50% of their genetic variation.
The purpose of this investigation is to quantitatively evaluate patterns of facial form and variance differences using threedimensional images of individuals with DS, euploid siblings of individuals with DS, and unrelated euploid controls. We hypothesize that the face of a person with DS will resemble his or her unaffected family members for some quantitative facial traits and will resemble other, unrelated persons with DS for other traits. Our expectation is that faces of age-matched children with DS and their siblings exhibit fewer significant form and variance differences relative to the faces of age-matched, unrelated euploid children. Furthermore, we expect stronger, more distinct patterns of variance differences to be present between age-matched children with DS and unrelated euploid controls.
| MATERIALS AND METHODS

| Down syndrome and euploid samples
We employ a three-sample study design to understand differences in facial morphology between samples of: 1) individuals with Down syndrome (hereafter referred to as the DS sample; n = 55); 2) euploid siblings of individuals with DS (hereafter referred to as the DSsib sample; n = 55); and 3) unrelated euploid individuals (hereafter referred to as the EU sample; n = 55). Each sample includes individuals ranging in age from 4 to 12 years that are age-matched across groups.
Individuals reported by parents to have DS from mosaicism, translocation, or mosaic translocation were excluded from analysis.
Sex ratios between age-matched samples are similar but not identical (sample 1: 45% male, 55% female; sample 2: 48% male, 52% female; sample 3: 38% male, 62% female). Precise matching by age and reported ethnicity was not possible, but the majority of individuals in each sample are Caucasian. Since ethnic differences have been found in previous publications on DS (Sforza et al., 2015) , the inability to precisely match ethnicity may influence the results. All individuals were recruited under protocols reviewed and approved by a duly constituted ethics committee (the Pennsylvania State University IRB # 23283 and #36627).
| Facial image acquisition and data collection
Three-dimensional facial images of each individual were acquired using the 3dMD photogrammatic system (3dMD, Atlanta, GA). This system acquires multiple images of an individual's face simultaneously and uses algorithms developed by 3dMD to automatically merge twodimensional images into a single three-dimensional surface. Images were acquired in <1.5 ms while each individual sat in an upright position and displayed a neutral facial expression. Previous studies have found that 3dMD surface images are accurate three-dimensional representations of facial topography and that three-dimensional locations of anatomical landmarks recorded from 3dMD images are accurately located and highly repeatable (Aldridge, Boyadjiev, Capone, DeLeon, & Richtsmeier, 2005; Weinberg et al., 2006; Wong et al., 2008) .
To assess measurement error of anatomical landmark placement, coordinates for twenty anatomical soft-tissue landmarks were collected repeatedly from surface images of five individuals drawn randomly from the overall sample (Supplemental Figure S1 ). Using 3dMDpatient (v4.0) software, each image was landmarked on five separate occasions, with at least 24 hr between landmarking sessions to avoid landmark placement memory bias. Standard deviations of landmark coordinate locations along the x, y, and z axes were averaged to calculate mean measurement error (Aldridge et al., 2005; . Mean measurement error local to each landmark was estimated to be 0.29 mm (0.26 mm along the x-dimension, 0.30 mm along the y-dimension, and 0.31 mm along the z-dimension) and is considered sufficiently low for the purposes of this study.
Following assessment of measurement error, anatomical landmark coordinates were recorded from each image on two separate occasions with at least 24 hr between landmarking trials as done in previous investigations (Starbuck, Cole, Reeves, & Richtsmeier, 2013; Starbuck, Ghoneima, & Kula, 2014; Starbuck, Reeves, & Richtsmeier, 2011) . After inspection of the data for gross landmarking errors (e.g., mislabeling right and left side landmarks), landmark coordinates were averaged from the two separate digitizing episodes to further minimize any potential effects of measurement error for each individual and these average measures were used in analyses.
| Analysis of facial morphology
Two tests were used to determine whether statistically significant differences in facial form exist between the samples. The first is a test for global form similarity using Euclidean Distance Matrix Analysis (EDMA) (Lele & Richtsmeier, 1991 . The size and shape of each individual was quantified using a form matrix (FM), consisting of the Euclidean distances between all pairs of landmarks. With 20 landmarks, there are 190 unique inter-landmark linear distances, and a mean form matrix (FM) was computed for each sample (Lele & Richtsmeier, 1995; Richtsmeier, Cole, & Lele, 2005; Richtsmeier, DeLeon, & Lele, 2002) .
Differences in mean form are compared using a form difference matrix (FDM), defined as a matrix of the ratios of all homologous linear distances between the sample mean forms. For example, to compare the DS and DSsib mean forms: FDM (DS,DSsib) ij = FM (DS) ij /FM(DSsib) ij , for every landmark pair i,j, where divisions are elementwise and 0/0 = 0. The null hypothesis is that the mean forms are the same, which would result in a FDM consisting of "1s" in all of the off-diagonal elements. The degree of the "overall" difference in form is measured by the statistic T = max/min (FDM). When two mean forms are identical (as expected under the null hypothesis), T = 1; T will increase as two forms become more different. The null hypothesis is evaluated using nonparametric bootstrapping (10,000 resamples) (Lele & Richtsmeier, 1991 ). We used a p-value of ≤0.05 to indicate rejection of the null hypothesis for the global EDMA test.
Localized differences in form (i.e., those involving specific linear distances) between samples were evaluated by computing confidence intervals for the ratios of homologous linear distances from each sample. Nonparametric bootstrapping was used to estimate 90% marginal confidence intervals (10,000 resamples) (Lele & Richtsmeier, 1995 . Global and local form analyses were carried out to estimate differences between the DS, DSsib, and EU samples.
Homologous measurements that significantly differed between the DS sample and both euploid samples are attributed to the effects of trisomy 21 (Figure 1 ).
To assess intra-and inter-specific facial variance and differences in facial variance, we conducted an EDMA-based ordination procedure known as principal coordinates analysis (PCOORD) (Gower, 1966; Reyment, Blackith, & Campbell, 1984; Richtsmeier, Cole, Krovitz, Valeri, & Lele, 1998) , which included individuals from all three samples (DS, DSsib, and EU). PCOORD summarizes the observed variation in form by projecting the samples into a low-dimensional space (i.e., two or three dimensions, compared to the number of interlandmark distances, which is 190). The purpose of this projection is to summarize complex patterns of variation in a way that makes them easier to interpret and visualize. Individuals that lie close together in the lowdimensional space are relatively similar in overall form, while more FIGURE 1 Diagram of how morphological differences are attributed to the effects of trisomy 21 and genetic relatedness (or lack thereof) among the Down syndrome (DS), Down syndrome sibling (DSsib), and unrelated euploid (EU) samples. A diagram of differences from two sample comparisons of the DS sample compared to DSsibs (left) and DS compared to EU (right) are shown. The DS sample is common to each two-sample analysis. Significant measurements are divided into those that overlap among twosample comparisons and those that do not. Homologous significant measurements from each two-sample comparison that included the DS sample are attributed to the effects of trisomy 21 on facial morphology. These corresponding differences were subtracted to remove the effects of DS on facial morphology and to explore morphological similarity between DSsibs, who share approximately 50% of alleles, and unrelated EU individuals 
This matrix serves as the basis for the PCOORD analysis. After double-centering the matrix, so that its rows and columns all sum to zero (Gower, 1966) , it is subjected to eigenanalysis, which projects the individuals into a low-dimensional space. The space is defined with respect to a series of mutually orthogonal principal coordinate axes.
The square roots of the resulting eigenvalues describe the lengths of the principal axes, and the eigenvectors are the "scores" that describe where individual subjects fall along each axis. Differences in the variances of interlandmark measures were assessed by a variant of the Hall-Martin test (Hall & Martin, 1988 ) that compares sample statistics using bootstrap confidence intervals. All computations were performed using the MIBoot program (Cole, 2002 involved in significant differences in facial morphology between these samples.
A test of global difference in morphology revealed that the faces of the DS and EU samples differ significantly (p-value = 0.001) ( Table 1) .
Approximately 46% (88/190) of the confidence intervals indicated significant differences between EU individuals and those with DS ( Figure 2b ). Similar to the comparison of DS and DSsib samples, all significant linear distances were an average of 9% smaller (range 6-18% smaller) in the DS sample, relative to homologous EU sample facial measures. The pattern of landmarks involved in significant linear distance differences between the DS and EU samples is similar to the differences defined between DS and DSsib samples above. The landmarks glabella, nasion, endocanthion, and exocanthion of the upper face contribute most frequently to the significant inter-sample differences, followed by midfacial landmarks pronasale and subnasale.
Globally, we failed to reject the null hypothesis of similarity in overall facial form between the DSsib and EU samples (p = 0.124) (Table 1) FIGURE 3 Principal coordinate analysis plot of the first two principal axes (PCs) for the Down syndrome (DS), Down syndrome siblings (DSsibs), and unrelated euploid (EU) samples and morphological differences associated with each PC. PCs 1 and 2 explain the majority of facial variation among samples (59.95%). Although samples overlap, much of the DS sample (circles, solid outline) is found along the negative end of PC1 relative to the euploid samples (DSsibs depicted as squares and dotted outline; EU depicted as triangles and dashed outline). Along both PCs the sample outlines suggest that the range of formspace occupied by the DS sample is larger than the two euploid samples. (Table 2) . These significant differences can be divided into those that are increased (23/27 i.e., 89%) or decreased (4/27 i.e., 11%) in the DS sample relative to euploid siblings. Those measurements whose variances are significantly increased exhibit an 84% average increase in variance (range of 58-125% increase) in the DS sample relative to the DSsib sample (Figure 4a ). Those metrics whose variances are significantly decreased exhibit a 40% mean decrease in variance (range of 33-48%) in the DSsib sample relative to the DS sample. The mid-and lower-face landmarks sublabiale, subalare, nasion, pogonion, and subnasale were most frequently involved in linear distances with variances that significantly differ between the DS and DSsib samples.
Nearly 18% (34/190) of linear distances have significantly unequal variances between the DS and EU samples (Table 2 ) and the variance is always relatively increased in the DS sample by an average of 74%
(range of 14-130%) (Figure 4b ). The mid-face landmarks subalare, crista philtra, pronasale, alar curvature, and chelion were most frequently involved in linear distances with variances that are significantly increased in the DS sample relative to EU samples.
When the two euploid samples (DSsib and EU) are compared, relatively few differences in variance were found, and because of the small number of differences, biological interpretations of them should be made with caution. Approximately 5% (10/190) of the linear distances have variances that differ significantly between the DSsib and EU samples (Table 2) . These significant differences can be divided into those that are increased (5/10 i.e., 50%) or decreased (5/10 i.e., 50%) in the DSsib sample relative to EU sample. Those measurements whose variances are significantly increased exhibit a 65% average increase (range of 60-70%) in the DSsib sample relative to the EU sample (Figure 4c ). Those metrics whose variances are significantly decreased exhibit a 41% mean decrease in variance (range of 34-50%) in the EU sample relative to the DSsib sample.
The landmarks chelion and subnasale were most frequently involved in linear distances with variances that significantly differ between the DSsib and EU samples.
The set of significant differences in facial variance between the DS and DSsibs samples, and between the DS and EU samples, (Figure 4d ), while remaining significant variance differences between the DS and EU samples are localized to the lower face around the mouth, chin, philtrum, inferior border of the nose, and nose width (Figure 4e ). This lack of correspondence in patterns of significant variance differences between DS and DSsibs, and DS and EU, after removing effects attributed to trisomy 21 (i.e., homologous significant differences between two-sample comparisons), provides indirect evidence that genetic relatedness or lack thereof influences patterns and localization of variance differences between samples.
| DISCUSSION
Craniofacial morphology is the result of a complex developmental program directed by manifold interactions of underlying genes and the environment. The roles of some of these genes in developmental processes are known, while others are yet to be discovered. Facial morphogenesis requires the correct spatiotemporal deployment of gene products, neural crest cells, and other cells to develop facial prominences, which in turn must form, grow, and merge according to a species-specific Bauplan (Brugmann, Kim, & Helms, 2006; Feng et al., 2009 ). Developmental deviations, such as those caused by trisomy 21
and gene-dosage imbalance, can lead to potentially detrimental birth defects and craniofacial anatomical changes by acting as a perturbation and modifying developmental morphogenetic pathways (Young et al., 2014) . Epigenetic effects may also influence facial form, but this topic is beyond the score of this paper which does not take into account any possible epigenetic effects of trisomy 21 on facial development.
The majority of studies assessing DS facial characteristics have done so by comparing and contrasting individuals with DS to unrelated "normal" or "typical" (i.e., euploid) individuals (Farkas, Katic, Forrest, & Litsas, 2001; Farkas, Katic, & Forrest, 2002a,b; Farkas, Munro, & Kolar, 1985; Ferrario, Dellavia, Colombo, & Sforza, 2004; Sforza et al., 2005 Sforza et al., , 2011 , thus confounding differences due to shared or unshared background genes with differences caused by trisomy 21. Although siblings share, on average, 50% of their genes, it has been argued that trisomy 21 alters facial morphology to such an extent that family resemblance is obscured (Opitz & Gilbert-Barness, 1990) . Research designs that compare a genetically perturbed human population to unrelated control groups are unable to partition variation due to differences in genetic background from those due the genetic perturbation being reported that faces of individuals with DS exhibit reduced facial dimensions including biocular distance, nasal height, width and protrusion, lip height, and mouth width (Farkas et al., 1985; Farkas, Katic, Forrest, & Litsas, 2001; Farkas, Posnick, & Hreczko, 1991; Ferrario, Dellavia, Colombo, et al., 2004; Ferrario, Dellavia, Zanotti, et al., 2004; Sforza et al., 2005 Sforza et al., , 2011 Sforza, Dellavia, Zanotti, Tartaglia, & Ferrario, 2004) . However, most facial measures of individuals with DS lie within the normal range established by previous investigations and those that do not tend to become more similar to measures from typical individuals as children mature into adults (Farkas et al., 2002a,b) . We found that many linear dimensions (i.e., 36-46%) of the face corresponding to those listed above are significantly reduced in children with DS, but overall a larger percentage of linear measures failed to reach statistical significance.
This is true for variance differences as well (14-18% differed significantly). Only a single measurement was significantly different between the two samples of euploid individuals (i.e., DSsibs and EU).
This result provides further evidence that the morphological differ- (Figures 4a and 4b) , respectively, resulting in unique patterns of midfacial and lower facial variance differences that remain even after significant effects attributed to trisomy 21 are removed (Figure 1 ). These results suggest that when DS and euploid individuals are siblings, the main differences in facial variance are localized to the midface, whereas when DS and euploid individuals are unrelated, the main differences in variance are localized to the lower face and the inferior portion of the midface, including the philtrum. Although trisomy 21 influences all facial regions, comparisons of age-matched samples that either share or do not share approximately 50% of their alleles, on average, yield different patterns of differences.
It has been reported that anatomy influenced by trisomy 21 is more variable than that of typical populations (Farkas et al., 1985; Sforza et al., 2004) . We found an approximate 2.8-to 3.6-fold increase (i.e., 14/5 to 18/5) in percentages of significant facial variance differences associated with the DS sample. Generally, these results concur with assertions from previous investigations, but our results differ because we have localized variance differences to particular facial regions, thereby illustrating that variance differences are not distributed evenly throughout the entire face.
Our quantitative analysis of multivariate formspace shows that the majority of DS faces fall within the distribution of euploid faces (Figure 3 ), despite the fact that the DS sample is consistently more FIGURE 5 Model of differences in distribution of facial measures for euploid (EU) and Down syndrome (DS) populations. The EU (solid) and DS (dotted) distributions are shown overlaid upon each other. Facial measures are represented along the y-axis. Along the x-axis each population has a mean trait value (μ), with most measures being reduced in the DS population due to impaired or reduced facial growth. The DS population is more variable as shown by the left tail of the DS distribution encapsulating most of the euploid distribution while simultaneously expanding outside of the typical EU range of variation and into a region of unique morphological variation represented by the right-side of the distribution tail-a region associated with the anatomical differences and "unique" constellation of facial phenotypic characteristics associated with DS. In the right tail of the DS distribution, those individuals just beyond the euploid range of variation may have a mild facial phenotype while those individuals further outside of the EU distribution may exhibit relatively more dysmorphology and perhaps more severe anatomical and health issues associated with the craniofacial complex 
